BioSpace News Archive

Net revenue from the company’s prescription prenatal vitamin business was approximately $4.4 million for the third quarter of 2017 compared with net revenue of approximately $5.5 million for the prior year’s quarter.

Insulet announced its intention to offer, subject to market and other conditions, $300 million principal amount of convertible senior notes due 2024 (the Notes) in a private placement.

For the third quarter of 2017, revenue was $17.5 million, compared to $18.6 million for the third quarter of 2016.

Net loss for the nine-month period ended September 30, 2017 was €20.8 million, compared to €16.1 million for the same period in the prior year.

Merck Animal Health has launched Care & Control of Pet Diabetes Featuring Sugar & Spike, a global educational program to provide pet owners with the tools they need to help manage their pets’ diabetes.

The results of this interim analysis, a pre-planned evaluation of data from an ongoing trial, show that TAK-003 is associated with a reduction in the incidence of dengue in children and adolescents.

announced today that the company is scheduled to present an update on the company’s programs and progress at several upcoming scientific conferences: Society for Immunotherapy of Cancer 32nd Annual Meeting, Society for Neuro Oncology 22nd Annual Meeting and American Society of Hematology 59th Annual Meeting.

This Note was retired exclusively through a one-time conversion exercised by GS Capital on November 2, 2017 for 83,597,839 shares of the Company’s common stock.

The BlueCielo acquisition is the latest in a series of strategic acquisitions fueling Accruent’s growth.

Microscopic analysis of neurons in the prefrontal cortex from the treated FXS mice showed an improvement in dendritic spine morphology.